Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-29T17:27:25.078Z Has data issue: false hasContentIssue false

P0283 - Atypical antipsychotics in epilepsy

Published online by Cambridge University Press:  16 April 2020

D. Marcoci
Affiliation:
University Clinic of Psychiatry, Craiova, Romania
A. Chirita
Affiliation:
University Clinic of Psychiatry, Craiova, Romania
D. Bondari
Affiliation:
University of Medicine and Pharmacy, Craiova, Romania

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Epilepsy is a neurological disease, always associating psychiatric troubles; these last ones can be permanent – unstable affect, dementia, or transient – delusions, hallucinations. Treatment in these patients is often difficult, because many antipsychotics may determine motor seizures and/or electroencephalographic changes.

Method:

We considered a sample of 35 epileptic patients (21 male and 14 female) with psychotic features, treated with specific antiepileptics and atypical antipsychotics (risperidone, olanzapine, quetiapine). It is well known that DA mediators partially inhibit motor seizures.

Results:

During one year, none of our patients related any increase of the frequency of seizures. Also, we did not highlight electroencephalographic changes in this period. Clinically, patients were assessed using PANSS scale.

Conclusion:

Atypical antipsychotics can be safety utilized in patients with epilepsy, ascertaining a good control of psychotic features, without worsening neurological symptomatology.

Type
Poster Session I: Neuroleptics and Antipsychotics
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.